An open, randomised, multicentre, phase 3 trial comparing the efficacy of two tamoxifen schedules in preventing gynaecomastia induced by bicalutamide monotherapy in prostate cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/19481335

Download in:

View as

General Info

PMID
19481335